Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-16-013409
Filing Date
2016-02-25
Accepted
2016-02-25 17:13:27
Documents
69
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mnov-10k_20151231.htm 10-K 2035822
2 EX-23.1 mnov-ex231_93.htm EX-23.1 2806
3 EX-23.2 mnov-ex232_616.htm EX-23.2 4620
4 EX-31.1 mnov-ex311_91.htm EX-31.1 8486
5 EX-31.2 mnov-ex312_92.htm EX-31.2 8444
6 EX-32.1 mnov-ex321_87.htm EX-32.1 6738
7 EX-32.2 mnov-ex322_86.htm EX-32.2 7046
  Complete submission text file 0001564590-16-013409.txt   6317744

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mnov-20151231.xml EX-101.INS 1193815
9 XBRL TAXONOMY EXTENSION SCHEMA mnov-20151231.xsd EX-101.SCH 44263
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20151231_cal.xml EX-101.CAL 46279
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20151231_def.xml EX-101.DEF 138828
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20151231_lab.xml EX-101.LAB 370433
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20151231_pre.xml EX-101.PRE 286309
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33185 | Film No.: 161456881
SIC: 2834 Pharmaceutical Preparations